Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson’s Disease

New paper in The Lancet Neurology proposes the first iteration of a research framework for defining and staging Parkinson’s disease (PD) based on biology, rather than clinical symptoms The framework defines PD based on the neuronal alpha-synuclein pathology that is a hallmark for the…